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Purpose: To identify a potential pathogenic mutation in a four-generation Chinese family with X-linked congenital
nystagmus (XLCN).
Methods: Routine clinical examination and ophthalmic evaluation were performed on normal controls, two patients and
two healthy members of the family. Genomic DNA was prepared from the peripheral blood of members of the family and
from 50 normal controls. All coding exons and the intronic boundaries of the four-point-one (4.1), ezrin, radixin,
moesin (FERM) domain-containing 7 (FRMD7) gene were amplified using polymerase chain reaction (PCR) followed
by direct sequencing.
Results: A previously unreported splicing mutation, c.163–1 G→T transversion (c.163–1 G>T), was detected preceding
exon3 of FRMD7 in the patients but not in the unaffected family members and 50 unrelated healthy individuals.
Conclusions: We identified a novel mutation (c.163–1 G→T) of FRMD7 in this Chinese family with XLCN. Our finding
is the first report related to c.163–1 G→T mutation in FRMD7. The result expands the mutation spectrum of FRMD7 in
association with congenital nystagmus.
Nystagmus  is  a  disease  characterized  by  rapid
involuntary movements of the eyes. This condition can affect
one or both eyes. The oscillations may be vertical, horizontal,
rotary, or mixed. Congenital nystagmus (CN) occurs at birth
or within the first few months of life without sensory defect.
The prevalence of CN is 1/20,000 and the etiology of CN is
not clear. Congenital nystagmus is different from “sensory
defect nystagmus” in that the former is a primary defect while
the latter is a result of other ocular diseases, such as albinism,
achromatopsia,  Leber  congenital  amaurosis,  congenital
cataract, and anterior segment dysgenesis [1,2].
Congenital  nystagmus  is  an  inherited  disease.  The
inheritance pattern is heterogeneous, but the most common
form is X-linked. So far, three loci for X-Linked congenital
nystagmus (XLCN, OMIM 310700, 300814, and 300589)
have been mapped to chromosomes Xq26–27 [3], Xp22 [4],
and Xp11.3–11.4 [5]. There are two genes that have been
identified as disease-causing genes for XLCN. These include
the G protein-coupled receptor 143 gene (GPR143) at Xp22
[4]  and  the  four-point-one  (4.1),  ezrin,  radixin,  moesin
(FERM) domain-containing 7 gene (FRMD7) at Xq26–27
[6]. The mutations in GPR143 have been reported to cause
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ocular albinism type 1 (OA1). In other studies, mutations in
FRMD7 were identified in families that were affected with X-
linked congenital nystagmus [6-15].
In  this  study,  we  performed  mutation  analysis  in
FRMD7 of a four-generation Chinese family affected with
XLCN.  A  novel  splicing  mutation  (c.163–1  G→T)  in
FRMD7 was detected in the patients but not in any of the
healthy family members or in the 50 healthy controls. This
finding suggests that the splice site mutation is responsible for
the disease in the family.
METHODS
Patients and clinical investigations: A four-generation Han
Chinese  family  with  CN  was  recruited  from  the  Second
Affiliated Hospital of Harbin Medical University, Harbin,
China. Two patients (III:7 and IV:9) and two healthy members
(III:1 and III:5) from this family participated in the study. In
addition, 50 subjects that have no diagnostic features of CN
were recruited from the Han Chinese population to serve as
normal controls. All participants underwent routine clinical
examination  and  ophthalmic  evaluation,  including  best-
corrected visual acuity in each eye, slit lamp biomicroscopy,
ophthalmoscopy, ocular motor examination for strabismus,
binocular sensorial testing of fusion and stereopsis, and the
examination of the optic nerve. After informed consent, 5 ml
of  peripheral  blood  samples  was  collected  from  the
participants in an ethylenediamine tetraacetic acid (EDTA)-
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87coated Vacutainer (BD, San Jose, CA). Genomic DNA was
extracted  using  the  TIANamp  Blood  DNA  Kit  (Tiangen
Biltech Co., Ltd., Beijing, China). This study was approved
by the Second Affiliated Hospital, Harbin Medical University
Ethics Committee of Harbin, China.
Mutation  analysis:  All  coding  exons  and  exon-intron
junctions of FRMD7 (NG_012347 and NM_194277) were
amplified through polymerase chain reaction (PCR) with the
primers  listed  in  Table1.  Primers  were  designed  using
Primer3plus and checked for specificity using Basic Local
Alignment Search Tool (BLAST). One hundred to 500 ng of
genomic DNA was amplified in a 50  μl reaction volume
containing the following: 50 μM dNTPs, 0.2 μM of each
primer, 2U Taq DNA polymerase, and 1× PCR reaction buffer
containing 1.5 mM MgCl2. The PCR cycling profile was as
follows: denaturation at 95 °C for five min, 32 cycles at 94 °C
for 30 s, annealing at the indicated temperature (Table 1) for
30 s, 72 °C for 45 s, and a final extension at 72 °C for 7 min.
The PCR products were visualized on a 1.5% agarose gel
containing  ethedium  bromide.  Sequence  analysis  was
performed with an ABI PRISM 3730XL Genetic Analyzer
(Applied  Biosystems,  Foster  City,  CA).  The  results  were
analyzed  using  Chromas  (version  1.0)  software  and  then
compared to the reference sequences of FRMD7 using Vector
NTI 10.3.0 (Invitrogen, Grand Island, NY). The result of the
splice  sites  was  predicted  using  Human  Splicing  Finder
(HSF)  Version  2.4.1  software.  We  used  the  Maximum
Consensus value to select the reliable Branch Point position.
Prediction  of  mutation-induced  splicing  alteration:  The
potential effect of the c.163–1 G→T mutation on the splicing
signals was predicted with the use of HSF software. Genomic
DNA sequences surrounding the mutant site were input into
the HSF to calculate the consensus values (CV) of potential
splice sites and to search for branch points. A higher consensus
value represents higher strength and more possibility for the
splice site to be authentic. Altering of the splice site may cause
the splicing to skip to the next authentic exon or to move to a
potential splice acceptor in high strength (CV>80) with an
appropriate high-strength upstream branch point (the CV>80
and located at 20–50 bp ahead of a consensus splice acceptor
site).
RESULTS
Clinical findings: There were nine affected individuals (five
females and four males) in the four-generation Han Chinese
family  (Figure  1).  No  male  to  male  transmission  was
observed. The proband (IV: 9) and his mother (III:7) had
nystagmus  as  the  first  symptom.  The  clinical  data  of  the
participants from the family are shown in Table 2. The patients
were excluded from albinism and were ascertained as X-
TABLE 1. PRIMERS AND PCR CONDITIONS FOR FRMD7.
Exon Forward primer(5′-3′) Reverse primer(5′-3′) Annealing
temperature
Product
size (bp)
1 CCTTGGGTGTGCATTACTTC TTTGCTATTGTTGTCCCTTGAG 57 °C 459
2 CGTGCTGCAGTATCAGGTTAG CCCTACATACCTAGCTGCAAAC 58 °C 243
3 TGACATTGCTGTTTGTTTCTACC TCTCAAAGCCCTTTTCTCCC 60 °C 304
4 GGAGAGAGCGGTGTGTGTGTG AGAATGGCCAGAAGCACTTG 61 °C 275
5 ATCTTGGATCTGGGAGAAGG GCTTGGTTCTCTACCTGGC 58 °C 238
6 GAGGACAAGGGTATGCTGGA TCAGGTTTAAGGGCTTGCTC 58 °C 281
7 GAGCTCTCAGGGTGGAAATG ACACCCAAGTTTGAGCCAAG 58 °C 293
8 GGCGGTCCCTCTCATTAAG AAACGATTTGCAGAAACAACC 59 °C 275
9 TTGGGATTTGAAGGTCTTTG TCCTAAGCCTCCTGTGTTATTG 58 °C 301
10+11 TTTAGTAGCCTATTGGTTTATGGC TCAATTCATGGAAGCATTTG 58 °C 401
12a GAGGCTAATTTAGATCCCTCCC CTGGCTTCATTGCAGTGGG 61 °C 620
12b TATGTGGACAAGCCACCCC CTTCAGCAGTTGGTGTGTTG 61 °C 613
12c TGAATCAGAGATTCTTAAACCA ACTGGGCCCCACACAAATAG 61 °C 649
Figure  1.  Pedigree  of  one  Chinese
family  with  X-linked  congenital
nystagmus. Peripheral blood (5 ml) was
drawn from certain members (III:1, III:
5, III:7, and IV:9) of the family. The
squares indicate males and the circles
indicate females. Black-filled symbols
indicate the persons affected with CN.
The  proband  is  denoted  by  the  black
arrow.
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88linked  congenital  nystagmus  based  on  the  detailed
ophthalmological examinations and their family history.
Mutation detected in FRMD7:  Direct sequencing analysis
detected a novel transversion, c.163–1 G→T, at the 3′-end of
intron 2 of FRMD7 in two affected individuals (Figure 2). This
mutation  is  located  within  the  splice  junction  consensus
sequences and is found to be abolishing the corresponding
splice acceptor site. This splice-site mutation, c.163–1 G→T,
was not found in the unaffected members of the family or in
the 50 unrelated controls.
The potential effects of c.163–1G→T mutation on the splicing
signal: Sequences that surround the c.163–1 G→T site were
calculated in HSF to find the cryptic splice sites by their
consensus values. The consensus values indicate the strength
that make the site a potential splice site. In the wild-type
sequence (Figure 3A), the authentic splice acceptor at the c.
163–1 site has a consensus value of 89.18 with a strong branch
point  (CV  87.28)  of  41  bp  upstream.  The  c.163–1G→T
mutant  abolishes  this  acceptor  motif.  The  nearby  cryptic
splice sites were evaluated by their consensus value and the
strength of their corresponding branch point to find the most
TABLE 2. THE CLINICAL FINDING OF INDIVIDUALS IN THIS STUDY.
       
Visual acuity at presentation 
 
Individual Age Sex Age at onset OD OS Clinical findings
IV:9 7 male since birth 20/60 20/60 rhythmical, repeated, horizontal
nystagmus of both eyes
III:7 35 female since birth 20/30 20/25 slight horizontal nystagmus of both eyes
III:1 52 male none 20/25 20/20 normal
III:5 48 male none 20/20 20/20 normal
Figure  2.  Sequence  analysis  of
FRMD7.  Sequencing  chromatograms
are  from  an  affected  female  patient
(top), an affected male (middle), and a
normal  individual  (bottom),  showing
the c.163–1 G→T transversion.
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89potential splice sites. A cryptic splice acceptor (CV 79.96) in
intron 3 with an appropriate high-strength branch point (CV
95.75 at −25 bp upstream) is predicted to produce a new exon
with  a  strong  downstream  donor  (CV  82.93;  Figure  3C).
Another  possible  splicing  type  induced  from  the  c.163–
1G→T mutant is generated by means of exon 3 skipping
(Figure  3B).  Both  predicted  mutant  transcripts  result  in
truncated proteins that lack the main functional domains due
to mutation-induced frame shifts that lead to premature stop
codon.
DISCUSSION
The  human  FRMD7  gene  consists  of  12  exons  spanning
approximately 51 kb on chromosome Xq26-q27. It encodes a
protein of 714 amino acids and shares a four-point-one, ezrin,
radixin, moesin (FERM) domain at its NH2-terminus with
band 4.1, ezrin, moesin, radixin, talin, filopodin, and merlin.
The FRMD7 protein has FERM-C, FERM-M, FA, FERM-N,
and B41 structural domains. The B41 domain (residues 1–
192) and the FERM-C domain (residues 186–279) are highly
conserved near the NH2-terminus. Although the function of
FRMD7 is not yet clear, two other FERM domain containing
proteins, pleckstrin domain protein 1 (FARP1) and FARP2,
have been extensively studied. FARP1 plays an important role
in the promotion of the dendritic growth of the spinal motor
neuron. FARP2 has been shown to modulate the length and
degree of neurite branching in developing cortical neurons.
In the present study, we report a novel G→T transversion
(c.163–1G→T) identified in the splice acceptor site on the
3′side of intron 2 of FRMD7 in an X-linked CN (XLCN)
family.  This  splice-site  mutation  was  not  found  in  the
unaffected members of the family or in the unrelated controls.
We predicted two most possible transcripts that may have
been induced by this splice-site mutation and both of them
produce truncated proteins (59 amino acids and 64 amino
acids, respectively) that lack the main functional domains
(Figure 3B,C). The lack of functional domains was considered
to seriously affect the function of these truncated proteins. The
software-predicted splicing is helpful in understanding the
potential effect of a splice-site mutation. So far, nine splicing
mutations have been reported in FRMD7 worldwide and all
of them were linked to XLCN. Collectively, our study and
published data support the theory that the splicing mutation c.
163–1G→T is the pathologic mutant for XLCN in the family.
In this study, we identified a novel splice-site mutation,
c.163–1G→T, in FRMD7 of a Chinese family that has X-
linked congenital nystagmus. To date, more than 40 mutations
in FRMD7 have been identified worldwide in families that
have  XLCN.  These  families  come  from  different  ethnic
groups [6-12,16,17]. According to the Human Gene Mutation
Database  (HGMD),  the  mutations  include  missense,
nonsense, splicing mutations, insertions, and deletions [18].
However, the underlying molecular mechanisms in CN are
not  fully  understood  yet.  Our  data  expands  the  mutation
spectrum of FRMD7 in causing congenital nystagmus and
may be helpful for understanding the molecular pathogenesis
of XLCN.
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Figure 3. Schematic diagram showing a possible consequence from the c.163–1G→T transversion in FRMD7. A: Schematic diagram of wild
type FRMD7. B: The mutant destroys the original splicing acceptor on the 3′ side of intron 2, and thus causes exon 3 (bases in green font)
skipping and creates a truncated protein of 64 amino acids. C: Another altered splicing introduces a new stop codon and creates a truncated
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